Search clinical trials for: Part1 : OPS-2071

Total 2306 results

University of Minnesota
Merck Sharp & Dohme LLC; University of Kentucky

Completed

Improving Adolescent Vaccination in Appalachian Kentucky (INSPIRE)

Adolescent Immunization

United States
Zimmer Biomet

Completed

A Study to Compare the NexGen LPS and LPS-Flex Knee Implants

Osteoarthritis | Total Knee Arthroplasty

United States, Canada
Nutricia Research

Completed

Amino Acid Bioavailability in Healthy Elderly After Intake of an Oral Nutritional Supplement (ArenA)

Sarcopenia

Netherlands
Cambridge Health Alliance
Foundation for Self Leadership

Active, not recruiting

Program for Alleviating and Reducing Trauma, Stress, and Substance Use ((PARTS-SUD))

PTSD | Substance Use Disorders

United States
Cambridge Health Alliance
Foundation for Self Leadership

Completed

Program for Alleviating and Resolving Trauma and Stress 1 (PARTS1)

Post-traumatic Stress Disorder

United States
Beth Israel Deaconess Medical Center

Withdrawn

OKS for Gait Instability

Gait, Unsteady | Vestibular Disorder

United States
Rigshospitalet, Denmark
Technical University of Denmark

Completed

Feedback Given by an Automatic and Objective System in Simulated Colonoscopy Increase Learning and Time Spent Practicing

Simulation Training | Education, Medical

Denmark
Verona Pharma plc
Iqvia Pty Ltd

Completed

Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler

Pulmonary Disease, Chronic Obstructive

United States
Emory University

Terminated

Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease

Sickle Cell Disease

United States
Laureate Institute for Brain Research, Inc.

Recruiting

Neural Response to Inflammatory Challenge in Major Depressive Disorder

Major Depressive Disorder

United States
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma (MM)

Japan
Optinose US Inc.

Recruiting

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Bilateral Nasal Polyposis

United States
University of Maryland, Baltimore

Withdrawn

Brain Biomarker on Inflammation Response (LPS)

Schizophrenia

United States
Yale University
National Institute of Mental Health (NIMH)

Active, not recruiting

Imaging the Neuroimmune System in PTSD

Post Traumatic Stress Disorder

United States
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, United Kingdom, Bulgaria, Canada, Georgia, Poland, Russian Federation, Sweden
Alteco Medical AB

Withdrawn

Remove LPS Registry

Suspected or Diagnosed Endotoxemia Casued by Gram-negative Bacteria
Oppilan Pharma Ltd
Celerion

Completed

A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers

Healthy

United Kingdom
Hospital Universitario 12 de Octubre
Apices Soluciones S.L.; Otsuka Pharmaceutical Co., Ltd.; Vivia Biotech

Completed

Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia

Acute Myeloid Leukemia

Spain
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term Trial of OPC-34712 in Patients With Schizophrenia

Schizophrenia

Japan
Carevive Systems, Inc.

Completed

Understanding Evidence-Based Practice Patterns in Advanced NSCLC

Non Small Cell Lung Cancer

United States
Carevive Systems, Inc.

Withdrawn

Metastatic Breast Cancer Treatment Planning

Metastatic Breast Cancer
Barmherzige Brüder Linz

Completed

Possible Links Between Inflammation and Lipid Metabolism

Sepsis | Inflammation | Lipid Metabolism Disorder | LPS

Austria
Carevive Systems, Inc.

Completed

Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma

Multiple Myeloma

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Multicenter, Open-label, Safety and Tolerability Study (STEP 210)

Schizophrenia

United States, Bulgaria, Philippines, Romania, Russian Federation, Serbia, Croatia, India, Korea, Republic of, Slovakia, Taiwan, Ukraine
Otsuka Pharmaceutical Co., Ltd.

Completed

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Acute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid Leukemia

Japan
Università degli Studi dell'Insubria

Completed

The Pain in Intensive Care Unit: Different Rating System Comparing (ICPain)

Critical Illness

Italy
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Non-Hodgkin's Lymphoma(NHL) | Multiple Myeloma(MM)

Hong Kong
QurAlis Corporation

Recruiting

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

Amyotrophic Lateral Sclerosis

Canada, Germany, Netherlands, Ireland, United Kingdom, Belgium
iN Therapeutics Co., Ltd.

Recruiting

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

Pain | Osteoarthritis | Chronic Pain | Neuropathic Pain | Post Herpetic Neuralgia

Australia
AstraZeneca
Acerta Pharma, LLC

Completed

A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects

Bioavailability | B-cell Lymphoid Cancer

United States
AstraZeneca

Completed

AZD1152 in Patients With Advanced Solid Malignancies

Tumors

United States
GlaxoSmithKline

Terminated

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting

United Kingdom
Addpharma Inc.

Not yet recruiting

Phase III Study to Evaluate the Efficacy and Safety of AD-209

Hypertension,Essential

Korea, Republic of
Ichnos Sciences SA
Glenmark Pharmaceuticals S.A.

Completed

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

United States, Canada, Czechia, Germany, Poland
Mereo BioPharma
Novartis

Terminated

Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery

Acute Kidney Injury

Taiwan, United States, Israel
UCB Pharma
Parexel

Completed

Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject

Psoriasis

United Kingdom
Modulation Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

Uveal Melanoma | Metastatic

United States
Royal Prince Alfred Hospital, Sydney, Australia

Completed

Evaluation of the Use of Cap in Improving the Performance of Colonoscopy

Colonoscopy

Australia
Tetherex Pharmaceuticals Corporation

Completed

Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
TransMedics

Recruiting

Sponsor-Initiated OCS Heart Perfusion Registry (OHP-II)

Heart Transplant

United States
Assiut University

Not yet recruiting

Mandibular Dimensions as a Predictor of Age and Sex in a Sample of Upper Egypt Population by Using Panoramic Images and Cone Beam Computed Tomography

Mandibular Dimensions
Mackay Memorial Hospital
Sanofi Taiwan Co. Ltd

Recruiting

The Intensively Follow-up Examinations for Asymptomatic MPS I Infants in Taiwan

MPS I

Taiwan
TransMedics

Active, not recruiting

OCS DCD Heart + CAP Continued Follow-Up

Heart Transplant

United States
Yale University

Completed

Neuroimmune Response to Lipopolysaccharide

Healthy

United States
Optinose US Inc.

Terminated

A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19

Covid19

Mexico
Alma Lasers

Withdrawn

Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study

Skin Resurfacing

United States
Carevive Systems, Inc.

Completed

Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study

CLL

United States
Assiut University

Unknown

Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic Nephropathy

Diabetic Nephropathies | Vascular Calcification

Egypt
Fraunhofer-Institute of Toxicology and Experimental...
Hannover Medical School

Completed

Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers

Healthy

Germany
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia (ZENITH)

Schizophrenia

Korea, Republic of, United States, Philippines, Malaysia, Croatia, Serbia, Russian Federation, Ukraine, Romania, Puerto Rico, Colombia, Turkey, Poland, Taiwan, Canada, Latvia, Slovakia, Mexico, Japan

Search clinical trials for: Part1 : OPS-2071

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations